Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 11/20 | 0.42 |
| ▸ | MAOA | P21397 | 10/20 | 0.42 |
| ▸ | APP | P05067 | 6/20 | 0.42 |
| ▸ | BCHE | P06276 | 8/20 | 0.41 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.41 |
| ▸ | ACHE | P22303 | 7/20 | 0.40 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4852558 | 1.00 | MAOB (0.42) | MAOBMAOAAPPBCHESLC6A9 | |
| SCHEMBL4850218 | 0.95 | SLC6A9 (0.44) | MAOBMAOAAPPBCHESLC6A9 | |
| SCHEMBL4849684 | 0.95 | SLC6A9 (0.44) | MAOBMAOAAPPBCHESLC6A9 | |
| SCHEMBL4856457 | 0.93 | SLC6A9 (0.43) | BCHESLC6A9ACHEPTPN11 | |
| SCHEMBL4854469 | 0.93 | SLC6A9 (0.43) | BCHESLC6A9ACHEPTPN11 | |
| SCHEMBL4845311 | 0.91 | MAOB (0.42) | MAOBMAOAAPPBCHEACHE | |
| SCHEMBL4853568 | 0.90 | SLC6A9 (0.46) | BCHESLC6A9ACHEPTPN11 | |
| SCHEMBL4847435 | 0.90 | SLC6A9 (0.46) | BCHESLC6A9ACHEPTPN11 | |
| SCHEMBL4853354 | 0.89 | SLC6A9 (0.40) | MAOBMAOAAPPBCHESLC6A9 | |
| SCHEMBL4852918 | 0.89 | SLC6A9 (0.40) | MAOBMAOAAPPBCHESLC6A9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050227990-A1 | Aminoalkoxy-functional chalcones | LICA PHARMACEUTICALS A/S (DK) | 2005-10-13 | — | — | US | claimed |
| US-7423181-B2 | in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone | LICA PHARMACEUTICALS A/S (DK) | 2008-09-09 | — | — | US | disclosed |
| EP-1515940-A2 | AMINOALKOXY-FUNCTIONAL CHALCONES | Lica Pharmaceuticals A/S (DK) | 2005-03-23 | — | — | EP | disclosed |
| WO-2003097574-A2 | AMINOALKOXY-FUNCTIONAL CHALCONES | LICA PHARMACEUTICALS A/S (DK) | 2003-11-27 | — | — | WO | disclosed |